Here are 12 key notes from orthopedic and spine device companies in the past week.
Medacta International appointed Francesco Siccardi as CEO, effective Nov. 1.
About a month after its billion-dollar acquisition of K2M, Stryker continues to make smaller acquisitions to complement its product portfolio.
The FDA granted Zimmer Biomet's request to extend its Mobi-C Cervical Disc labeling to include seven-year clinical results.
On Sept. 28, the Securities and Exchange Commission charged Stryker with violating the books and records and internal accounting controls provisions for the Foreign Corrupt Practices Act.
TeDan Surgical Innovations and Lattus Spine entered into an exclusive partnership with 4Web Medical to market 4Web's Extreme Lateral Access platform.
DePuy Synthes, a Johnson & Johnson company, launched Sentio MMG, a digital mechanomyography platform designed to assess nerve status.
Arvind Dubey, MD, implanted his 1,000th level of Centinel Spine's STALIF C-Ti Anterior Cervical Integrated Interbody device at the Royal Hobart Hospital in Tasmania, Australia.
Stryker received FDA 510(k) clearance for its SpineJack Implantable Fracture Reduction System.
NuVasive enrolled the first patients in its study comparing lateral lumbar interbody fusion outcomes with traditional smooth PEEK intervertebral spacers and two NuVasive Advanced Materials Science portfolio implants.
SeaSpine released the Regatta Lateral System, which features NanoMetalene technology.
Vertos Medical enrolled the first patient into a nationwide study of its mild procedure, a minimally invasive lumbar spinal stenosis treatment.
Zeiss Meditec launched the Tivato 700 for minimally invasive spine surgery at the North American Spine Society Annual Meeting in Los Angeles, Sept. 26-29.